AKT Inhibitors: New Weapons in the Fight Against Breast Cancer? by Federica Martorana, Federica Martorana, Gianmarco Motta, Gianmarco Motta, Giuliana Pavone, Giuliana Pavone, Lucia Motta, Lucia Motta, Stefania Stella, Stefania Stella, Silvia Rita Vitale, Silvia Rita Vitale, Livia Manzella, Livia Manzella, Paolo Vigneri, Paolo Vigneri, Paolo Vigneri

Connect to this object online.

Type 2 diabetes and cancer: problems and suggestions for best patient management by Agostino Milluzzo, Paolo Vigneri, Federica Martorana, Riccardo Vigneri, Laura Sciacca

Connect to this object online.

Abemaciclib pharmacology and interactions in the treatment of HR+/HER2− breast cancer: a critical review by Federica Martorana, Maria Vita Sanò, Maria Rosaria Valerio, Stefano Fogli, Paolo Vigneri, Romano Danesi, Vittorio Gebbia

Connect to this object online.

Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts by Michele Massimino, Michele Massimino, Elena Tirrò, Elena Tirrò, Stefania Stella, Stefania Stella, Livia Manzella, Livia Manzella, Maria Stella Pennisi, Maria Stella Pennisi, Chiara Romano, Chiara Romano, Silvia Rita Vitale, Silvia Rita Vitale, Adriana Puma, Adriana Puma, Cristina Tomarchio, Cristina Tomarchio, Sandra Di Gregorio, Sandra Di Gregorio, Agostino Antolino, Francesco Di Raimondo, Francesco Di Raimondo, Paolo Vigneri, Paolo Vigneri

Connect to this object online.